Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Antioxidants Offer Pain Relief for Patients with Chronic Pancreatitis

By HospiMedica International staff writers
Posted on 12 Jan 2009
A new study has found that antioxidant supplementation is effective in relieving pain and reducing levels of oxidative stress in patients with chronic pancreatitis (CP).

Researchers at the All India Institute of Medical Sciences (AIIMS, New Delhi) conducted a placebo controlled, double-blind trial of127 patients (aged 30.5 +/- 10.5 years), who were assigned to a placebo or an antioxidant group. More...
The primary outcome measure was pain relief, and secondary outcome measures included analgesic requirements, hospitalization, and markers of oxidative stress and antioxidant status, as measured by the ferric-reducing ability of plasma (FRAP).

The study results showed that after six months, the reduction in the number of painful days per month was significantly higher in the antioxidant group, compared with the placebo group. The reduction in the number of analgesic tablets per month was also higher in the antioxidant group. The reduction in the level of oxidative stress and the increase in FRAP were significantly higher in the antioxidant group compared with the placebo group. Furthermore, 32% and 13% of patients became pain free in the antioxidant and placebo groups, respectively. The beneficial effect of antioxidants on pain relief in this case was noted at three months. The study was published in the January 2009 issue of Gastroenterology.

"We are encouraged by our findings, as significant improvement was noted with antioxidants in respect to all the parameters of pain in this study,” said lead author Pramod Kumar Garg, M.D., of the department of gastroenterology. "In addition, reduction in pain resulted in fewer man-days lost, thus providing functional employment gain to the patients. The findings should spur further research in this exciting area.”

CP is a progressive inflammatory disease of the pancreas in which patients experience abdominal pain (in early stage), and diabetes and maldigestion (in late stage). Pain is the major problem in 90% of patients, and usually has a sudden onset often caused by gallstones, alcohol abuse, or genetic mutations. Symptoms start with a gradual or sudden severe pain in the central part of the upper abdomen, penetrating through to the back. Treatment often focuses on the nutritional and metabolic needs of the patient and on relieving pain, but there is currently no effective medical therapy for pain relief.

Related Links:
All India Institute of Medical Sciences


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.